Share-based Payment Arrangement, Expense of Lexaria Bioscience Corp. from 31 Aug 2016 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lexaria Bioscience Corp. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Aug 2016 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Share-based Payment Arrangement, Expense for the quarter ending 30 Nov 2025 was $74,895, a 25% decline year-over-year.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2025 was $859,494, a 75% increase from 2024.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2024 was $492,236, a 189% increase from 2023.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2023 was $170,382, a 77% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $74,895 -$24,520 -25% 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q4 2024 $99,415 +$45,462 +84% 01 Sep 2024 30 Nov 2024 10-Q 13 Jan 2026 2026 Q1
Q4 2023 $155,559 $53,953 -$14,823 -22% 01 Sep 2023 30 Nov 2023 10-Q 10 Jan 2025 2025 Q1
Q3 2023 $170,382 $9,634 01 Jun 2023 31 Aug 2023 10-K 20 Nov 2023 2023 FY
Q2 2023 $81,446 -$29,728 -27% 01 Mar 2023 31 May 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 $10,526 01 Dec 2022 28 Feb 2023 10-Q 14 Jul 2023 2023 Q3
Q4 2022 $68,776 -$339,768 -83% 01 Sep 2022 30 Nov 2022 10-Q 14 Jul 2023 2023 Q3
Q2 2022 $111,174 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2023 Q3
Q4 2021 $408,544 +$359,657 +736% 01 Sep 2021 30 Nov 2021 10-Q 14 Jul 2023 2023 Q3
Q4 2020 $48,887 -$113,527 -70% 01 Sep 2020 30 Nov 2020 10-Q 14 Jan 2022 2022 Q1
Q4 2019 $162,414 +$98,370 +154% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q4 2018 $64,044 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1

Lexaria Bioscience Corp. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $859,494 +$367,258 +75% 01 Sep 2024 31 Aug 2025 10-K 28 Nov 2025 2025 FY
2024 $492,236 +$321,854 +189% 01 Sep 2023 31 Aug 2024 10-K 28 Nov 2025 2025 FY
2023 $170,382 -$582,209 -77% 01 Sep 2022 31 Aug 2023 10-K 20 Nov 2023 2023 FY
2022 $752,591 +$342,584 +84% 01 Sep 2021 31 Aug 2022 10-K 20 Nov 2023 2023 FY
2021 $410,007 -$729,263 -64% 01 Sep 2020 31 Aug 2021 10-K 28 Nov 2022 2022 FY
2020 $1,139,270 +$512,578 +82% 01 Sep 2019 31 Aug 2020 10-K 29 Nov 2021 2021 FY
2019 $626,692 -$1,975,547 -76% 01 Sep 2018 31 Aug 2019 10-K 15 Oct 2020 2020 FY
2018 $2,602,239 +$2,489,195 +2202% 01 Sep 2017 31 Aug 2018 10-K 14 Nov 2019 2019 FY
2017 $113,044 -$8,971 -7.4% 01 Sep 2016 31 Aug 2017 10-K 14 Nov 2018 2018 FY
2016 $122,015 01 Sep 2015 31 Aug 2016 10-K 14 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.